Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trial

A Martin, J Amin, DA Cooper, A Carr, AD Kelleher… - Aids, 2010 - journals.lww.com
Objective: The Simplification of antiretroviral therapy with Tenofovir-Emtricitabine or
Abacavir-Lamivudine trial (STEAL) study randomized HIV participants to switch existing …
被引用次数：71 相关文章

Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trial.

A Martin, J Amin, DA Cooper, A Carr… - AIDS (London …, 2010 - europepmc.org
Objective The Simplification of antiretroviral therapy with Tenofovir-Emtricitabine or Abacavir-
Lamivudine trial (STEAL) study randomized HIV participants to switch existing nucleoside …

Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trial.

A Martin, J Amin, DA Cooper, A Carr, AD Kelleher… - 2010 - cabidigitallibrary.org
Abstract Objective: The Simplification of antiretroviral therapy with Tenofovir-Emtricitabine or
Abacavir-Lamivudine trial (STEAL) study randomized HIV participants to switch existing …

Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trial

A Martin, J Amin, DA Cooper, A Carr, AD Kelleher… - 2010 - pubmed.ncbi.nlm.nih.gov
Objective The Simplification of antiretroviral therapy with Tenofovir-Emtricitabine or Abacavir-
Lamivudine trial (STEAL) study randomized HIV participants to switch existing nucleoside …

Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: A randomized clinical trial

A Martin, J Amin, DA Cooper, A Carr… - …, 2010 - researchportal.murdoch.edu.au
Objective: The Simplification of antiretroviral therapy with Tenofovir-Emtricitabine or
Abacavir-Lamivudine trial (STEAL) study randomized HIV participants to switch existing …

Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trial

A Martin, J Amin, DA Cooper, A Carr, AD Kelleher… - 2010 - ro.uow.edu.au
Objective: The Simplification of antiretroviral therapy with Tenofovir-Emtricitabine or
Abacavir-Lamivudine trial (STEAL) study randomized HIV participants to switch existing …

Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: A randomized clinical trial

A Martin, J Amin, DA Cooper, A Carr, AD Kelleher… - AIDS, 2010 - research.monash.edu
Objective: The Simplification of antiretroviral therapy with Tenofovir-Emtricitabine or
Abacavir-Lamivudine trial (STEAL) study randomized HIV participants to switch existing …

[引用][C] Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trial

A MARTIN, J AMIN, DA COOPER, A CARR… - AIDS …, 2010 - pascal-francis.inist.fr
Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in
suppressed HIV: a randomized clinical trial CNRS Inist Pascal-Francis CNRS Pascal and …

Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trial

A Martin, J Amin, DA Cooper, A Carr, AD Kelleher… - AIDS, 2010 - researchers.mq.edu.au
Objective: The Simplification of antiretroviral therapy with Tenofovir-Emtricitabine or
Abacavir-Lamivudine trial (STEAL) study randomized HIV participants to switch existing …

[引用][C] Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trial

A Martin, J Amin, DA Cooper, A Carr, AD Kelleher… - AIDS, 2010 - espace.library.uq.edu.au
Objective: The Simplification of antiretroviral therapy with Tenofovir-Emtricitabine or
Abacavir-Lamivudine trial (STEAL) study randomized HIV participants to switch existing …